Interleukin-6 as a potential biomarker of COVID-19 progression

Med Mal Infect. 2020 Jun;50(4):382-383. doi: 10.1016/j.medmal.2020.04.002. Epub 2020 Apr 4.
No abstract available

Keywords: Biomarker; COVID-19; IL-6.

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Betacoronavirus / isolation & purification
  • Biomarkers / blood*
  • COVID-19
  • Coronavirus Infections / blood
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / pathology
  • Humans
  • Interleukin-6 / blood*
  • Pandemics
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / pathology
  • SARS-CoV-2
  • Severity of Illness Index

Substances

  • Biomarkers
  • Interleukin-6